6VSZ

Crystal structure of a human afucosylated IgG1 Fc expressed in tobacco plants (Nicotiana benthamiana)

6VSZ の概要

• エントリーDOI: 10.2210/pdb6vsz/pdb
• 分子名称: Immunoglobulin gamma-1 heavy chain, beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose (3 entities in total)
• 機能のキーワード: immune system, immunoglobulin, crystallizable fragment, igg1, fc
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 50794.78

構造登録者

Tolbert, W.D.,Pazgier, M. (登録日: 2020-02-12, 公開日: 2021-02-17, 最終更新日: 2024-10-16)

主引用文献

Anand, S.P.,Ding, S.,Tolbert, W.D.,Prevost, J.,Richard, J.,Gil, H.M.,Gendron-Lepage, G.,Cheung, W.F.,Wang, H.,Pastora, R.,Saxena, H.,Wakarchuk, W.,Medjahed, H.,Wines, B.D.,Hogarth, M.,Shaw, G.M.,Martin, M.A.,Burton, D.R.,Hangartner, L.,Evans, D.T.,Pazgier, M.,Cossar, D.,McLean, M.D.,Finzi, A.
Enhanced Ability of Plant-Derived PGT121 Glycovariants To Eliminate HIV-1-Infected Cells.
J.Virol., 95:e0079621-e0079621, 2021

PubMed Abstract: The activity of broadly neutralizing antibodies (bNAbs) targeting HIV-1 depends on pleiotropic functions, including viral neutralization and the elimination of HIV-1-infected cells. Several studies have suggested that passive administration of bNAbs represents a valuable strategy for the prevention or treatment of HIV-1. In addition, different strategies are currently being tested to scale up the production of bNAbs to obtain the large quantities of antibodies required for clinical trials. Production of antibodies in plants permits low-cost and large-scale production of valuable therapeutics; furthermore, pertinent to this work, it also includes an advanced glycoengineering platform. In this study, we used Nicotiana benthamiana to produce different Fc-glycovariants of a potent bNAb, PGT121, with near-homogeneous profiles and evaluated their antiviral activities. Structural analyses identified a close similarity in overall structure and glycosylation patterns of Fc regions for these plant-derived Abs and mammalian cell-derived Abs. When tested for Fc-effector activities, afucosylated PGT121 showed significantly enhanced FcγRIIIa interaction and antibody dependent cellular cytotoxicity (ADCC) against primary HIV-1-infected cells, both and . However, the overall galactosylation profiles of plant PGT121 did not affect ADCC activities against infected primary CD4 T cells. Our results suggest that the abrogation of the Fc N-linked glycan fucosylation of PGT121 is a worthwhile strategy to boost its Fc-effector functionality. PGT121 is a highly potent bNAb and its antiviral activities for HIV-1 prevention and therapy are currently being evaluated in clinical trials. The importance of its Fc-effector functions in clearing HIV-1-infected cells is also under investigation. Our results highlight enhanced Fc-effector activities of afucosylated PGT121 MAbs that could be important in a therapeutic context to accelerate infected cell clearance and slow disease progression. Future studies to evaluate the potential of plant-produced afucosylated PGT121 in controlling HIV-1 replication are warranted.

PubMed: 34232070
DOI: 10.1128/JVI.00796-21

実験手法

X-RAY DIFFRACTION (2.6 Å)